Does PEMBROLIZUMAB Cause Neoplasm? 49 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 49 reports of Neoplasm have been filed in association with PEMBROLIZUMAB (KEYTRUDA). This represents 0.1% of all adverse event reports for PEMBROLIZUMAB.
49
Reports of Neoplasm with PEMBROLIZUMAB
0.1%
of all PEMBROLIZUMAB reports
10
Deaths
18
Hospitalizations
How Dangerous Is Neoplasm From PEMBROLIZUMAB?
Of the 49 reports, 10 (20.4%) resulted in death, 18 (36.7%) required hospitalization, and 4 (8.2%) were considered life-threatening.
Is Neoplasm Listed in the Official Label?
Yes, Neoplasm is listed as a known adverse reaction in the official FDA drug label for PEMBROLIZUMAB.
What Other Side Effects Does PEMBROLIZUMAB Cause?
Malignant neoplasm progression (10,111)
Death (4,744)
Diarrhoea (4,251)
Fatigue (3,833)
Off label use (3,416)
Product use in unapproved indication (3,191)
Pyrexia (3,155)
Rash (2,900)
Nausea (2,670)
Decreased appetite (2,486)
What Other Drugs Cause Neoplasm?
ADALIMUMAB (513)
OCTREOTIDE (366)
RITUXIMAB (323)
LENALIDOMIDE (242)
CYCLOPHOSPHAMIDE (221)
BEVACIZUMAB (207)
INFLIXIMAB (201)
ETANERCEPT (194)
RIBOCICLIB (194)
METHOTREXATE (165)
Which PEMBROLIZUMAB Alternatives Have Lower Neoplasm Risk?
PEMBROLIZUMAB vs PEMETREXED
PEMBROLIZUMAB vs PEMIGATINIB
PEMBROLIZUMAB vs PENICILLAMINE
PEMBROLIZUMAB vs PENICILLIN
PEMBROLIZUMAB vs PENICILLIN G